Lake County Emergency Management Agency Director Joe Busher recently delivered “positive” news to the Lake County ...

The drugmaker said this morning that an application for sipavibart (AZD3152) has been accepted for review by the EMA as PrEP for immunocompromised patients who often do not respond adequately to ...

Granite Construction is a top pick for roadwork investments as federal spending boosts infrastructure. Learn why GVA stock is ...

WACO, Texas (KWTX) - Vanguard College Preparatory School senior, Ema Mathis, wrote a children’s book to teach the importance ...

On Wednesday, UNM officially welcomed Seattle's Jaylen Petty and Issac Williamson of Eastvale, California as the first Class of 2025 recruits to sign scholarship papers. Each guard had announced their ...

Target patient enrollment of 92 evaluable patients achieved in the VIRAGE Phase 2b clinical trial of VCN-01 in patients with metastatic ...

MDNA11 continues to show best-in-class potential in the ABILITY-1 study with an objective response rate (ORR) of 30% in the monotherapy dose expansion cohort among patients with cancer progression ...

Dr Taruna Kamal cleared the Union Public Service Commission (UPSC) exam on her first attempt, securing the 203rd rank in the ...

Good afternoon and welcome to today's conference call for Omeros Corporation. (Operator Instructions) Please be advised that this call is being recorded at the company's request and a replay will be ...

SHELTON, CT / ACCESSWIRE / November 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the quarter ending September 30 ...

Increlex is an FDA and EMA approved product for the treatment of severe primary ... Our team is hard at work on all other aspects of launch preparation, including our marketing campaign. In addition, ...

Cellectar broadens global manufacturing network in preparation for potential commercialization of Iopofosine I 131 in 2025.